Citadel Advisors’s scPharmaceuticals SCPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $496K | Buy |
130,075
+91,412
| +236% | +$348K | ﹤0.01% | 4074 |
|
|
2025
Q1 | $102K | Buy |
+38,663
| New | +$102K | ﹤0.01% | 5147 |
|
|
2024
Q4 | – | Sell |
-525,964
| Closed | -$2.4M | – | 6674 |
|
|
2024
Q3 | $2.4M | Sell |
525,964
-209,440
| -28% | -$955K | ﹤0.01% | 2341 |
|
|
2024
Q2 | $3.2M | Buy |
735,404
+158,491
| +27% | +$689K | ﹤0.01% | 2024 |
|
|
2024
Q1 | $2.9M | Buy |
576,913
+437,417
| +314% | +$2.2M | ﹤0.01% | 2183 |
|
|
2023
Q4 | $875K | Buy |
139,496
+134,506
| +2,696% | +$843K | ﹤0.01% | 3167 |
|
|
2023
Q3 | $35.5K | Buy |
4,990
+4,937
| +9,315% | +$35.2K | ﹤0.01% | 5194 |
|
|
2023
Q2 | $540 | Sell |
53
-93,069
| -100% | -$948K | ﹤0.01% | 5654 |
|
|
2023
Q1 | $845K | Sell |
93,122
-55,586
| -37% | -$504K | ﹤0.01% | 3348 |
|
|
2022
Q4 | $1.07M | Buy |
148,708
+120,772
| +432% | +$866K | ﹤0.01% | 3146 |
|
|
2022
Q3 | $182K | Sell |
27,936
-19,298
| -41% | -$126K | ﹤0.01% | 4897 |
|
|
2022
Q2 | $228K | Buy |
47,234
+15,740
| +50% | +$76K | ﹤0.01% | 4895 |
|
|
2022
Q1 | $179K | Buy |
+31,494
| New | +$179K | ﹤0.01% | 5370 |
|
|
2020
Q3 | – | Sell |
-54,277
| Closed | -$399K | – | 5185 |
|
|
2020
Q2 | $399K | Buy |
+54,277
| New | +$399K | ﹤0.01% | 3607 |
|
|
2018
Q3 | – | Sell |
-16,828
| Closed | -$95K | – | 4670 |
|
|
2018
Q2 | $95K | Buy |
+16,828
| New | +$95K | ﹤0.01% | 3842 |
|